APEXIGEN INC has a total of 90 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2011. It filed its patents most often in China, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and audio-visual technology are INHIBRX LLC, BEIJING WISDOMAB BIOTECHNOLOGY CO LTD and ARGEN-X N V.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 12 | |
#2 | United States | 12 | |
#3 | EPO (European Patent Office) | 10 | |
#4 | WIPO (World Intellectual Property Organization) | 10 | |
#5 | Australia | 7 | |
#6 | Canada | 6 | |
#7 | Hong Kong | 5 | |
#8 | Japan | 5 | |
#9 | Republic of Korea | 5 | |
#10 | Israel | 4 | |
#11 | Mexico | 4 | |
#12 | Brazil | 3 | |
#13 | New Zealand | 3 | |
#14 | South Africa | 2 | |
#15 | Singapore | 1 | |
#16 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Audio-visual technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Casings and printed circuits | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Yongke | 64 |
#2 | Zhu Weimin | 53 |
#3 | Yu Guo-Liang | 45 |
#4 | Ke Yaohuang | 26 |
#5 | Lee Sum Wai Pierre | 22 |
#6 | Yang Xiaodong | 21 |
#7 | Filbert Erin L | 13 |
#8 | Björck Pia | 9 |
#9 | Tan Christine | 8 |
#10 | Zhang Yong-Ke | 5 |
Publication | Filing date | Title |
---|---|---|
WO2021055253A2 | Anti-tnfr2 antibodies and methods of use | |
EP3740509A1 | Anti-pd-l1 antibodies and methods of use | |
EP3642231A1 | Anti-vista antibodies and methods of use | |
AU2017353852A1 | Anti-CD40 antibodies in combination and methods of use | |
EP2970462A1 | Anti-rankl antibodies and methods of use | |
CA2888763A1 | Anti-cd40 antibodies and methods of use | |
AU2012318246A1 | Anti-KDR antibodies and methods of use | |
CN106928362A | Anti-CD 40 antibodies and its application method | |
CN104650229A | Anti-KDR antibodies and methods of use | |
CA2827581A1 | Anti-il-6 receptor antibodies and methods of use | |
CN103328511A | Anti-Il-1 beta antibodies and methods of use |